Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
PaperCitations, authors & open-access status
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 308 citations, 2021 year and hybrid oa status.
308
Citations
2021
Year
hybrid
OA Status